More and more imaging researchers are starting to examine the potential of using fibroblast activation protein inhibitors (FAPI) to manage patients with suspected cardiovascular disease.
The BENEFIT-HF trial, scheduled to begin enrollment in the months ahead, could significantly increase the number of patients eligible for CVRx's Barostim therapy.
Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.
Gene-editing drugs have shown potential to treat a wide variety of diseases, and this will be one of the first in cardiovascular medicine to begin human trials.
For patients who were hospitalized, but not yet in the ICU, those randomly assigned a higher-dose of anticoagulants had lower 30-day mortality risk than those on a lower dose.
Axillary lymphadenopathy following COVID vaccination and/or boosters is a finding all radiologists must be mindful of when interpreting imaging, but new data clarify the timeline for when the side effect should resolve.
The risk stratification system was put to the test in more than 3,000 cases and proved itself to be a beneficial tool in predicting future AVM rupture across multiple risk groups.
Many patients who would clearly benefit by lowered LDL cholesterol levels are choosing to forgo first-time recommendations for statin regimens, according to a population-level study.
People over age 50 with chronic knee can pain enjoy significant pain reduction after genicular nerve radiofrequency ablation, according to new research to be presented at the Society of Interventional Radiology’s Annual Scientific Meeting in Phoenix, Arizona.
A team of experts has been researching a method known as photo acoustic chemical imaging, or PACI, to understand how it can offer added insight into the chemical makeup of a tumor.
Experts are hopeful that the first-of-its-kind injectable manganese-based macrocyclic agent will offer a suitable alternative to GBCAs, as it can be more efficiently eliminated from the body.
